We help Chinese pharma companies
enter the European market.
Regulatory expertise. Clinical trial access. Business development. We cover every stage of EU market entry — on a fixed-fee or retainer basis.
Request a ConsultationEU Product Registration
Full IMPD preparation, EMA centralised procedure submissions, and national regulatory filings across EU member states.
Clinical Trial Navigation
CRO selection, EU clinical trial site identification, and end-to-end regulatory pathway management for Phase I–III studies.
Regulatory Affairs Advisory
Ongoing EU regulatory strategy, dossier management, and expert guidance on evolving EMA guidelines and requirements.
Business Development & Partner Finding
Identification of EU licensing candidates, structured partner introductions, and deal structuring support for cross-border transactions.
Three steps. No surprises.
All engagements are confidential. We work on a fixed-fee or retainer basis — agreed in writing before any work begins.
Start the Conversation